Technology | Magnetic Resonance Imaging (MRI) | October 12, 2016

Software quantifies key features of MRI brain scans to help monitor brain changes over time

icometrix, icobrain, MRI brain scans, longitudinal measurements, RSNA 2016, FDA clearance

October 12, 2016 — The health tech company Icometrix obtained 510(k) clearance in September from the U.S. Food and Drug Administration (FDA) for their image quantification software, icobrain. The software quantifies key features of clinical magnetic resonance imaging (MRI) brain scans, which enable clinicians to monitor how their patient's brain changes over time.

As the only software currently available that has been scientifically validated and clinically approved for longitudinal measurements, according to the company, icobrain offers clinicians unrivalled access to unique information about disease progression and the effect of treatment upon brain structure.

"MRI biomarkers are becoming of vital importance in the clinical care path for various pathologies, including neurological disorders such as multiple sclerosis, traumatic brain injury and stroke. It is of paramount importance that the biomarker measurements are extremely reproducible and sensitive enough to detect relevant clinical changes", said Max Wintermark, M.D., professor of radiology and chief of neuroradiology at the Stanford University Medical Center. "The icometrix methods have been published in several scientific journals and validated by top centers worldwide, demonstrating the accuracy that is needed to translate measures from a research setting to routine clinical practice," Wintermark added.

Icometrix' analysis services help radiologists and physicians worldwide to improve and personalize the care of patients with a neurological disorder, such as multiple sclerosis, traumatic brain injury or dementia. Accessing the U.S. market is an important step and will lead to more evidence-based medicine by bringing automated MRI reports into clinical practice.

For more information: www.icometrix.com

Related Content

News | MRI Breast

June 22, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), contrast-enhanced mammography (CEM) may be a ...

Time June 22, 2022
arrow
News | Artificial Intelligence

June 9, 2022 — Infinitt North America and Brainreader A/S announced today a wide ranging and unique partnership to ...

Time June 09, 2022
arrow
News | Ultrasound Imaging

June 7, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), ultrasound-derived fat fraction (UDFF) is ...

Time June 07, 2022
arrow
News | Radiation Therapy

June 3, 2022 — Henry Ford Health is the first in the world to complete a full course of patient treatments using the ...

Time June 03, 2022
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

Time June 01, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

June 1, 2022 — SyntheticMR, an innovative software solutions company for magnetic resonance imaging announced hat their ...

Time June 01, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 25, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), adding diffusion-weighted MRI (DWI) to ...

Time May 25, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 13, 2022 — Alzheimer’s disease is the most common form of dementia, one of the major causes of dependency and ...

Time May 13, 2022
arrow
News | Contrast Media

May 13, 2022 — The ACR Committee on Drugs and Contrast Media, within the ACR Commission on Quality and Safety, is aware ...

Time May 13, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 10, 2022 — At the ISMRM 2022 conference, Bruker announced the launch of innovative 7 Tesla and 9.4 Tesla conduction ...

Time May 10, 2022
arrow
Subscribe Now